Oncolytics Biotech (ONCY) Tops Q3 EPS by 1c

Oncolytics Biotech (NASDAQ: ONCY) reported Q3 EPS of ($0.05), $0.01 better than the analyst estimate of ($0.06).

For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.

You May Also Be Interested In

• Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
• Micron Technology (MU) Tops Q3 EPS by $4.62, Guidance Beats
• Morgan Stanley raises dividend 15% and approves $20B buyback program